Patent · US Active

Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof

US11053199B2 · kind B2 · utility

1Cited by

0References

15Claims

0Family size

Assignees

CELGENE CORPORATION · US
Abide Therapeutics, Inc. · US

Inventors

Lianfeng Huang · Jalan Pedongkelan, US
Nancy Tsou · Westfield, US
Nicole S. White · San Diego, US
Jun Xu · Gaithersburg, US
Qun Zhang · Nanhu, CN

Key dates

Filing date	Sep 12, 2019
Grant date	Jul 6, 2021
Priority date	—
Expiry date	Sep 12, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Provided herein are crystalline forms of (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate. Pharmaceutical compositions comprising crystalline forms of (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.